Petlife Pharmaceuticals Inc. logo

Petlife Pharmaceuticals Inc. (PTLF)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
19.68K Market Cap
0.01 P/E Ratio
- Div Yield
500 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track PTLF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PTLF closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly decrease of -50% or $0. Over the past 12 months, PTLF stock gained 0%.
PTLF is not paying dividends to its shareholders.
The last earnings report, released on Nov 30, 2016, missed the consensus estimates by -0.8831%. On average, the company has fell short of earnings expectations by -0.4104%, based on the last three reports.
Petlife Pharmaceuticals Inc. has completed 5 stock splits, with the recent split occurring on Sep 12, 2016.
The company's stock is traded on one exchange.

PTLF Chart

Petlife Pharmaceuticals Inc. (PTLF) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Petlife Pharmaceuticals Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is PTLF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 19.68K.

Has Petlife Pharmaceuticals Inc. ever had a stock split?

Petlife Pharmaceuticals Inc. had 5 splits and the recent split was on Sep 12, 2016.

Petlife Pharmaceuticals Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Sebastian Serrell-Watts CEO
OTC PINK Exchange
71639C103 CUSIP
US Country
1 Employees
- Last Dividend
12 Aug 2014 Last Split
- IPO Date

Overview

Petlife Pharmaceuticals, Inc. is a company committed to the advancement of veterinary medicine, focusing on the development and sale of pharmaceuticals and nutraceuticals aimed at treating pet cancer and autoimmune diseases, such as arthritis. Based in Los Angeles, California, they are pioneering in their approach to pet health, especially in the realm of serious diseases afflicting pets across the United States. Their research and development efforts are primarily centered on Vitalzul, their flagship product, which targets the inhibition of blood vessel formation in solid tumors—an innovative approach to cancer treatment in pets.

Products and Services

  • Vitalzul

    This principal product by Petlife Pharmaceuticals is designed to combat pet cancer by inhibiting angiogenesis, the formation of new blood vessels, thereby preventing the growth and spread of solid tumors. Vitalzul is in the process of being developed not just as an oral medication that pet owners can easily administer, but also as a more potent, concentrated formula for intravenous and injectable use, meant for direct application to tumors by veterinary professionals.

  • Oral Pharmaceuticals

    Building on the foundation laid by Vitalzul, Petlife is expanding its portfolio to include prescription-strength oral pharmaceuticals. These are specifically designed for pets suffering from cancer and autoimmune diseases, offering a more accessible and non-invasive treatment option for pet owners and their beloved animals.

  • Concentrated Intravenous and Injectable Versions

    For more aggressive treatment approaches, Petlife is developing concentrated versions of Vitalzul intended for intravenous and injectable administration. This form of treatment is ideal for direct administration to tumors, offering a targeted approach to combating cancer in pets. This development represents a significant step forward in veterinary cancer treatment, providing more options for veterinarians and pet owners dealing with advanced cases.

  • Edible Dog and Cat Treats

    Recognizing the importance of ease of use and the challenge of administering medication to pets, Petlife is also innovating in the area of pet nutrition by developing edible treats for dogs and cats. These treats are not only palatable but are also designed to deliver health benefits, supporting the overall well-being of pets and potentially easing the symptoms of diseases like cancer and arthritis.

Contact Information

Address: 8033 Sunset Boulevard
Phone: 424-216-6807